Trademark applications and grants for Zymogenetics Inc. Zymogenetics Inc has 70 trademark applications. The latest application filed is for "ZYMOGENETICS"
Patent Application | Date |
---|---|
COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES 20220002419 - 17/483262 GAO; Zeren ;   et al. | 2022-01-06 |
LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS 20210139577 - 17/115326 Dillon; Stacey R. ;   et al. | 2021-05-13 |
METHODS OF TREATING PRURIGO NODULARIS USING ANTI-IL-31RA ANTIBODY COMPOSITIONS 20200239581 - Bilsborough; Janine M. | 2020-07-30 |
TREATING INFLAMMATION WITH SOLUBLE HYBRID FCGAMMA RECEPTORS 20200131245 - 16/737039 BIRKS; Carl W. ;   et al. | 2020-04-30 |
COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES 20190375843 - 16/540819 GAO; Zeren ;   et al. | 2019-12-12 |
NCAGE Code | 54SK9 | ZYMOGENETICS, INC. |
CAGE Code | 54SK9 | ZYMOGENETICS, INC. |
SEC | 0001129425 | ZYMOGENETICS INC of WASHINGTON |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.